抗PD-1抗体和抗PD-L1抗体临床使用的护理综述

相 前
中国医学科学院肿瘤医院

摘要

近年来，肿瘤免疫治疗逐渐成为肿瘤治疗领域的研究热点，在肿瘤综合治疗中发挥了巨大作用。本文以相关文献作为研究基础，同时结合相关临床工作经验，对使用抗PD-1的抗体及抗PD-L1抗体的护理进行综述分析，希望通过本文的研究能够为相关临床实践提供一定的理论依据。

关键词

PD-1抗体；抗PD-L1抗体；护理

参考

[1]Champiat S, Lambotte O, Barreau E, et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol,2016,27(4): 559-74. [2]Boutros C, Tarhini A, Routier E, et al. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.LID - 10.1038/nrclinonc.2016.58 [J]. Nat Rev Clin Oncol,2016(6):12. [3]EigentlerTK,HasselJC,BerkingC,etal.Diagnosis,monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy.Cancer Treat Rev,2016.(5):7-18. [4]Daniel Y. Wang et al. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis. JAMA Oncology,2018(1):12.